TP53 and neoplasm: This finding appears to be so consistent, at least in the spectrum of p53KO-driven tumors, that it suggests that restraining Myc levels, rather than guarding against the effects of unrepaired random DNA damage per se, constitutes the major p53 tumor suppressor function.